Core Viewpoint - Medline (MDLN), a newly listed medical supplies company, experienced a 3.5% decline in early trading after completing the largest IPO of 2025, raising $6.26 billion, with a first-day stock price surge of 41% and a valuation of approximately $54 billion, despite facing tariff headwinds, investors remain optimistic about its stable cash flow [1] Group 1 - Medline completed its IPO, raising $6.26 billion, marking the largest IPO of 2025 [1] - The stock price increased by 41% on its first day of trading [1] - The company's valuation reached approximately $54 billion [1] Group 2 - Medline's stock declined by 3.5% in early trading following the IPO [1] - Investors are betting on the company's stable cash flow despite tariff challenges [1]
次新股Medline小幅下跌 昨日飙升41%